Enliven Therapeutics, Inc. (ELVN): SC 13G filed Feb 3, 2021

Form type

SC 13G

Filing date

Feb 3, 2021

Accession number

0001193125-21-027355

Filer

Enliven Therapeutics, Inc. (CIK 1672619)